What is the ticker symbol for Protalix BioTherapeutics?

Protalix BioTherapeutics trades under the ticker PLX on AMEX.

What sector does Protalix BioTherapeutics operate in?

Protalix BioTherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PLX in a portfolio?

PortView shows PLX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Protalix BioTherapeutics (PLX) Stock Analysis

AMEXHealthcareBiotechnology

$2.60+2.77%

1-year price historyRange $1.67 – $3.15

52-week range$2.60

$1.65$3.19

Track PLX in your portfolio for free · Portfolio tracker

What Protalix BioTherapeutics does

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.

Key metrics

Market cap

$209.49M

P/E (TTM)

11.30

EPS (TTM)

$0.23

Beta

0.01

Dividend yield

0.00%

Revenue / share

$1.01

50-day avg

$2.63

200-day avg

$2.41

52-week high

$3.19

52-week low

$1.65

CEO

Dror Bashan

ETFs linked to PLX

Broad-market and Healthcare sector ETFs an investor holding Protalix BioTherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PLX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PLX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Protalix BioTherapeutics?: Protalix BioTherapeutics trades under the ticker PLX on AMEX.
Which exchange is PLX listed on?: PLX is listed on AMEX.
What sector does Protalix BioTherapeutics operate in?: Protalix BioTherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PLX in a portfolio?: PortView shows PLX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.